918

A NOVEL SELF-ASSEMBLING PEPTIDE HYDROGEL FOR WOUND HEALING: INITIAL RESULTS FOR ENDOSCOPIC TREATMENT OF POST-SURGICAL LEAKS

Date
May 20, 2024

Introduction:
A novel, self-assembling peptide hydrogel (PuraStat, 3D Matrix, Tokyo, Japan) has recently been FDA-approved with dual indications for hemostasis and wound healing. Initial endoscopic clinical reports of this self-assembling peptide hydrogel (SAPH) have focused on hemostasis, including mild to moderate bleeding associated with conditions like gastric antral vascular ectasia (GAVE), radiation proctitis, as well as post-ESD or EMR wound healing. However, its potential for endoscopic treatment of post-surgical leaks remains relatively unexplored. Our study aims to fill this gap presenting a case series of SAPH specifically in the context of wound healing for post-bariatric surgery leaks.

Case Description/Methods:

Patient 1: 39-year-old male POD5 from RYGB reversal to LSG/duodenal switch presented with half circumferential dehiscence of the duodenal-ileal (DI) anastomosis. The DI leak was endoscopically treated with 2 transmural double pigtail plastic stents (DPPS). By POD50, the DI leak had near-resolved, and both DPPS and the percutaneous drain had been removed. However, there remained a small fistulous tract that was injected with 3 mL of SAPH. By POD89, the fistula tract was fully healed.

Patient 2: 48-year-old female POD31 from LSG presented with a large 4cm proximal staple line dehiscence. Initial treatment was endoscopic vacuum therapy, but it was discontinued after 1 week due to patient intolerance. A covered esophageal metal stent was placed but similarly removed after 1 week due to patient intolerance. These therapies led to 50% cavity reduction. Septotomy was not possible. The cavity was further treated with double pigtail plastic stents and SAPH injection but ultimately persisted, necessitating revisional surgery with fistula-jejunostomy.

Patient 3: 28-year-old male POD10 from LSG presented with a moderate proximal staple line leak accompanied by the development of a proximal-lateral sleeve fistula tract. Extensive lavage was performed in fistula cavity. 3mL SAPH was injected into the area of fistula without concurrent stent placement. By POD143, the fistula tract had healed.

Patient 4: 39-year-old female with LSG, complicated by small, chronic (>2 years) gastric sleeve leak and two fistula tracts (2mm and 6mm), leading to a supradiaphragmatic collection. 9mL SAPH was injected in a 3:1 ratio with contrast through both fistula cavities. One of the two fistulous tracts healed.

Discussion:
Self-Assembling Peptide Hydrogel (SAPH), which has already shown promise for hemostasis, is potentially also an adjunctive wound-healing agent for treatment of post-surgical leaks. It is relatively easy to inject through a catheter and combines well with conventional endoscopic treatments. Our small case series suggests that SAPH may be most helpful for small and/or early gastrointestinal leaks and fistulae. Larger studies are required.
<b>Table 1: Baseline Characteristics. </b>This table provides an overview of the study results, including demographic information, description of complications, and outcomes.

Table 1: Baseline Characteristics. This table provides an overview of the study results, including demographic information, description of complications, and outcomes.

<b>Figure 1: (a) </b>Injection of Self-Assembling Peptide Hydrogel (SAPH) into small fistulous tract (note: reflux of clear gel after filling tract). <b>(b) </b>Healed fistulous tract.

Figure 1: (a) Injection of Self-Assembling Peptide Hydrogel (SAPH) into small fistulous tract (note: reflux of clear gel after filling tract). (b) Healed fistulous tract.


Tracks

Related Products

Thumbnail for ADVANCED LIVER FIBROSIS IS ASSOCIATED WITH DECREASED WEIGHT LOSS AFTER BARIATRIC SURGERY
ADVANCED LIVER FIBROSIS IS ASSOCIATED WITH DECREASED WEIGHT LOSS AFTER BARIATRIC SURGERY
Laparoscopic fundoplication in patients with a history of lung transplant has an average length of stay (LOS) of 3 days with a 30-day readmission rate of 25%, which is significantly worse compared to the non-lung transplant population…
Thumbnail for METABOLIC OUTCOMES AND MECHANISMS OF ACTION FOR DUODENAL BI-PARTITION IN THE TREATMENT OF OBESITY AND TYPE 2 DIABETES MELLITUS: A 4-YEAR PROSPECTIVE OBSERVATIONAL STUDY
METABOLIC OUTCOMES AND MECHANISMS OF ACTION FOR DUODENAL BI-PARTITION IN THE TREATMENT OF OBESITY AND TYPE 2 DIABETES MELLITUS: A 4-YEAR PROSPECTIVE OBSERVATIONAL STUDY
INTRODUCTION: Roux-en-Y gastric bypass (RYGB) is an effective treatment for patients suffering from obesity and concomitant type 2 diabetes mellitus (T2DM). Nevertheless, less than 2% of eligible patients choose to undergo the surgery…
Thumbnail for GASTROENTEROLOGY SPECIFIC AI MODEL OUTPERFORMS ATTENDING PHYSICIAN CLINICAL NOTES IN A REAL-WORLD DATA EVALUATION
GASTROENTEROLOGY SPECIFIC AI MODEL OUTPERFORMS ATTENDING PHYSICIAN CLINICAL NOTES IN A REAL-WORLD DATA EVALUATION
INTRODUCTION: Artificial Intelligence (AI) large language models (LLMs) show promise in medicine, however general-purpose AI models underperform on clinical tasks. Recognizing this potential, our team developed a specialty-specific multi-task clinical LLM: GastroGPT (Fig 1)…
Thumbnail for THE MULTIVIEW PERSPECTIVE (MVP) STUDY: A BLINDED, TANDEM PROSPECTIVE TRIAL OF FORWARD-VIEW VERSUS SIDE-VIEW EXAMINATION DURING ERCP
THE MULTIVIEW PERSPECTIVE (MVP) STUDY: A BLINDED, TANDEM PROSPECTIVE TRIAL OF FORWARD-VIEW VERSUS SIDE-VIEW EXAMINATION DURING ERCP
INTRODUCTION: Most endoscopists perform ERCP with only a side-viewing duodenoscope. We hypothesize significant gastrointestinal findings are missed due to the side-viewing design of the duodenoscope and that at least a subset of patients would benefit from concomitant forward-viewing exam (i.e…